Esperion Therapeutics Statistics
Total Valuation
ESPR has a market cap or net worth of $798.11 million. The enterprise value is $1.31 billion.
Important Dates
The next estimated earnings date is Tuesday, March 3, 2026, before market open.
| Earnings Date | Mar 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ESPR has 235.43 million shares outstanding. The number of shares has increased by 18.70% in one year.
| Current Share Class | 235.43M |
| Shares Outstanding | 235.43M |
| Shares Change (YoY) | +18.70% |
| Shares Change (QoQ) | +1.61% |
| Owned by Insiders (%) | 0.91% |
| Owned by Institutions (%) | 46.30% |
| Float | 233.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 11.02 |
| PS Ratio | 2.20 |
| Forward PS | 1.63 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.00
| Current Ratio | 1.00 |
| Quick Ratio | 0.59 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.37 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -5.42% |
| Return on Invested Capital (ROIC) | -10.83% |
| Return on Capital Employed (ROCE) | -589.13% |
| Weighted Average Cost of Capital (WACC) | 10.12% |
| Revenue Per Employee | $999,349 |
| Profits Per Employee | -$348,128 |
| Employee Count | 304 |
| Asset Turnover | 0.90 |
| Inventory Turnover | 1.55 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +79.37% in the last 52 weeks. The beta is 1.04, so ESPR's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | +79.37% |
| 50-Day Moving Average | 3.58 |
| 200-Day Moving Average | 2.25 |
| Relative Strength Index (RSI) | 48.29 |
| Average Volume (20 Days) | 5,797,669 |
Short Selling Information
The latest short interest is 37.44 million, so 15.90% of the outstanding shares have been sold short.
| Short Interest | 37.44M |
| Short Previous Month | 33.93M |
| Short % of Shares Out | 15.90% |
| Short % of Float | 16.05% |
| Short Ratio (days to cover) | 6.69 |
Income Statement
In the last 12 months, ESPR had revenue of $303.80 million and -$105.83 million in losses. Loss per share was -$0.54.
| Revenue | 303.80M |
| Gross Profit | 131.90M |
| Operating Income | -29.38M |
| Pretax Income | -105.83M |
| Net Income | -105.83M |
| EBITDA | -29.27M |
| EBIT | -29.38M |
| Loss Per Share | -$0.54 |
Full Income StatementBalance Sheet
The company has $92.45 million in cash and $600.99 million in debt, with a net cash position of -$508.54 million or -$2.16 per share.
| Cash & Cash Equivalents | 92.45M |
| Total Debt | 600.99M |
| Net Cash | -508.54M |
| Net Cash Per Share | -$2.16 |
| Equity (Book Value) | -451.36M |
| Book Value Per Share | -2.20 |
| Working Capital | 1.43M |
Full Balance SheetCash Flow
| Operating Cash Flow | -93.29M |
| Capital Expenditures | n/a |
| Free Cash Flow | -93.29M |
| FCF Per Share | -$0.40 |
Full Cash Flow StatementMargins
Gross margin is 43.42%, with operating and profit margins of -9.67% and -34.84%.
| Gross Margin | 43.42% |
| Operating Margin | -9.67% |
| Pretax Margin | -34.84% |
| Profit Margin | -34.84% |
| EBITDA Margin | -9.64% |
| EBIT Margin | -9.67% |
| FCF Margin | n/a |
Dividends & Yields
ESPR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.70% |
| Shareholder Yield | -18.70% |
| Earnings Yield | -13.26% |
| FCF Yield | -11.69% |
Analyst Forecast
The average price target for ESPR is $6.67, which is 96.76% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.67 |
| Price Target Difference | 96.76% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 23.02% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ESPR has an Altman Z-Score of -5.65 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.65 |
| Piotroski F-Score | 2 |
